Sutro Biopharma Inc

NASDAQ:STRO   11:06:09 AM EDT
6.52
-0.12 (-1.81%)
Products, Strategic Combinations

Astellas And Sutro Biopharma Announce Worldwide Strategic Collaboration To Advance Novel Immunostimulatory Antibody-Drug Conjugates

Published: 06/27/2022 23:38 GMT
Sutro Biopharma Inc (STRO) - Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-drug Conjugates (iadcs).
Sutro Biopharma Inc - Will Receive an Upfront Payment of Us$90 Million to Develop Iadcs for Three Biological Targets.
Sutro - May Be Eligible to Receive Up to Additional $422.5 Million in Milestones for Each Product Candidate Plus Royalties.